학술논문

Hemoglobin E disease and glycosylated hemoglobin
Document Type
article
Source
Indian Journal of Endocrinology and Metabolism, Vol 19, Iss 5, Pp 683-685 (2015)
Subject
Glycosylated hemoglobin
hemoglobin E variant
interference
North-east India
Diseases of the endocrine glands. Clinical endocrinology
RC648-665
Diseases of the digestive system. Gastroenterology
RC799-869
Language
English
ISSN
2230-8210
2230-9500
Abstract
Glycosylated hemoglobin (HbA1C) is a routinely measured parameter to monitor long-term glycemic control in people with diabetes mellitus. The presence of hemoglobin (Hb) variants can affect the accuracy of HbA1C methods. Hb E variant is the most common Hb variant in South-east Asia and North-east India. In the presence of Hb E, HbA1C may not be detectable by ion-exchange chromatography (high-pressure liquid chromatography), but may be estimated by immunoassay technique and boronate affinity chromatography. However, the result may be underestimated when correlated with plasma glucose and serum fructosamine levels. Clinicians should be aware of this limitation of HbA1C estimation in patients with Hb E and other Hb variants.